Related Experiment Video
Updated: May 3, 2026
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
1.4K
Metabolomics applied in neonatology
Nicoletta Iacovidou1, Aggelikì Syggelou, Athanasios Chalkias
1Neonatal Division, National & Kapodistrian University of Athens, Athens, Greece.
Bioanalysis
|January 30, 2014
Summary
Host-response biomarkers, including metabolites in plasma, urine, and maternal milk, offer insights into neonatal health. These markers aid in predicting disease severity and personalizing interventions for better outcomes.
Area of Science:
- Biomarkers
- Neonatology
- Metabolomics
Background:
- Host-response biomarkers are crucial for understanding biological processes and disease severity.
- Individual factors like age, diet, and medical history provide valuable biomarker information.
- Biomarkers aid in complete phenotyping of biological systems.
Purpose of the Study:
- To review existing literature on host-response biomarkers in neonatology.
- To examine metabolites in plasma, urine, and maternal milk for neonatal health insights.
- To highlight the role of biomarkers in predicting disease outcome and personalizing interventions.
Main Methods:
- Literature review of host-response biomarkers in neonatology.
- Analysis of data on metabolites in neonatal biological samples (plasma, urine, milk).
- Examination of biomarker utility for disease phenotyping and outcome prediction.
Main Results:
- Host-response biomarkers provide dynamic insights into neonatal conditions.
- Metabolites in plasma, urine, and maternal milk are key indicators.
- Biomarkers facilitate personalized medical interventions in neonates.
Conclusions:
- Host-response biomarkers are vital for understanding neonatal health and disease.
- Metabolite analysis in neonatal samples aids in predicting outcomes.
- Personalized interventions based on biomarkers can improve neonatal care.
